Streetbeat News

Stock Prices

VRDN

Viridian Therapeutics' stock price increased following the announcement of their Q4 financial results. Additionally, Wedbush reaffirmed an Outperform rating and increased the price target for VRDN from $39 to $40.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 5:16 pm

PRKS

United Parks & Resorts Inc. (NYSE:PRKS) reported a slight decline in Q4 fiscal 2023 revenue by 0.4% Y/Y to $389 million, despite a small increase in attendance. Net income and adjusted EBITDA also saw declines of 18.3% and 2.1% Y/Y, respectively. The company announced a new $500 million share buyback program and highlighted the successful opening of its first SeaWorld park in Abu Dhabi. PRKS shares rose by 8.97% to $53.19.

Portfolio Pulse from Akanksha Bakshi

February 28, 2024 | 5:16 pm

OKTA

Whales have shown a bearish stance on Okta (NASDAQ:OKTA), with options trading indicating a split sentiment of 44% bullish and 55% bearish. Notable options activity includes a mix of calls and puts, targeting a price range of $70.0 to $105.0 for Okta. The company, a cloud-native security firm focusing on identity and access management, is currently trading at $86.14, down by -0.89%, with an anticipated earnings release in 0 days.

Portfolio Pulse from Benzinga Insights

February 28, 2024 | 5:15 pm

ARKK

COIN

Coinbase Global, Inc. (NASDAQ:COIN) shares are trading higher, influenced by Bitcoin's surge above $60,000, its highest since November 2021. Factors like the upcoming Bitcoin halving event and the approval of spot Bitcoin ETFs have increased demand for Bitcoin. Ark Invest sold 46,531 Coinbase shares through its ARK Innovation ETF (NYSE:ARKK). The article also discusses the challenges of predicting long-term stock prices, using Coinbase's past performance to forecast its future price.

Portfolio Pulse from Erica Kollmann

February 28, 2024 | 5:13 pm

UWMC

UWM Holdings shares are trading lower following the announcement of worse-than-expected Q4 financial results.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 5:13 pm

VIPS

Vipshop Holdings Limited (NYSE:VIPS) shares surged after reporting Q4 adjusted earnings per ADS of 82 cents, beating the consensus of 71 cents, and revenues of $4.88 billion, exceeding expectations of $4.69 billion. Sales grew 9.2% YoY, driven by increased active customers and spending in discretionary categories. GMV and total orders saw significant increases, while gross profit rose 19.3% YoY. The company declared a dividend of $0.43 per ADS for FY2023 and provided a positive revenue outlook for Q1 2024.

Portfolio Pulse from Nabaparna Bhattacharya

February 28, 2024 | 5:11 pm

FLGT

Fulgent Genetics' stock price declined following the announcement of Q4 financial results and FY24 guidance that fell short of expectations.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 5:07 pm

LLY

NVO

VKTX

Viking Therapeutics Inc (NASDAQ:VKTX) released successful Phase 2 weight loss trial results for VK2735, showing significant reductions in body weight compared to placebo. The results outperformed Novo Nordisk A/S's (NYSE:NVO) and Eli Lilly And Co's (NYSE:LLY) similar trials. Viking also announced a $350 million capital raise. Analysts from HC Wainwright and William Blair highlighted VK2735's superior performance and revised its peak sales estimate upwards. VKTX shares rose 9.34% to $92.99.

Portfolio Pulse from Vandana Singh

February 28, 2024 | 5:05 pm

ASTE

Astec Industries' shares surged following the announcement of their Q4 adjusted EPS results, which exceeded expectations.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 5:05 pm

DAKT

Daktronics shares are trading higher following the announcement of their Q3 financial results.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 5:03 pm